Biomimetic Glycosaminoglycan‐Analog Hydrogel for Improved Embolization of Aneurysms: Environment‐Selective Swelling
Advanced Healthcare Materials · 2025-07 · 14 (17)
DOI: 10.1002/adhm.202404506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 07.04.2025. Verfasst von Sarit S Sivan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology Engineering, Braude College of Engineering, Karmiel, 2161002, Israel. Hauptthemen laut MEDLINE: Hydrogels, Embolization, Therapeutic, Biomimetic Materials, Glycosaminoglycans. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Research Council, The Braude Seed Research Fund.
Abstract (Originalsprache)
Injectable hydrogels are promising biomaterials for treating aneurysms, life‐threatening blood‐filled saccular lesions, enabling complete filling of the aneurysm and supporting tissue repair. Yet, the challenge is to enable clinical translation as hydrogels must not protrude into the parent vessel, nor migrate from the aneurysm cavity. Here, injectable, negatively‐charged, biologically and mechanically compatible hydrogels with environment‐sensitive swelling capabilities that cease swelling upon contact with blood are developed. Hydrogels are fabricated by copolymerizing sodium 2‐acrylamido‐2‐methylpropanesulfonic acid (NaAMPS) and 3‐sulfopropyl acrylate (KSPA) by using polyethylene glycol diacrylate (PEGDA). Three formulations (2%, 4%, and 6%) demonstrating a wide range of physiological‐relevant stiffnesses are fabricated. The selected mechano‐compatible 4% hydrogel exhibits a suitable swelling pressure (125 kPa) and supports high endothelial cell viability (> 75%). Importantly, the hydrogel demonstrates a significant differential swell with respect to blood (30 ± 4%), plasma (58 ± 3%), and PBS (82 ± 2%). This environment‐selective swelling, upon exposure to blood, results in minimal directional swelling toward the parent artery, which can improve embolization outcomes. Hydrogel embolization in 3D‐printed aneurysm models subjected to physiological blood flow shows no protrusion toward the main artery while completely blocking flow into the aneurysm. This approach provides promising opportunities for efficient embolization of a variety of aneurysms and vascular malformations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology Engineering, Braude College of Engineering, Karmiel, 2161002, Israel.
- Department of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa, 32000, Israel.
ORCID-Profile: Maria Khoury, Netanel Korin
Förderung
- H2020 European Research Council
- The Braude Seed Research Fund
Zitieren
APA
Sivan, S. S., Bonshtein, I., Khoury, M., Kreinin, Y., Korneyev, D., Mekler, T., Kaiyal, S., Weitz, I. S., & Korin, N. (2025). Biomimetic Glycosaminoglycan‐Analog Hydrogel for Improved Embolization of Aneurysms: Environment‐Selective Swelling. Advanced Healthcare Materials, 14(17). https://doi.org/10.1002/adhm.202404506
Vancouver
Sivan SS, Bonshtein I, Khoury M, Kreinin Y, Korneyev D, Mekler T, et al. Biomimetic Glycosaminoglycan‐Analog Hydrogel for Improved Embolization of Aneurysms: Environment‐Selective Swelling. Advanced Healthcare Materials. 2025;14(17). doi:10.1002/adhm.202404506
BibTeX
@article{Sivan2025,
author = {Sivan, Sarit S and Bonshtein, Iris and Khoury, Maria and Kreinin, Yevgeniy and Korneyev, Dmitry and Mekler, Tirosh and Kaiyal, Sumaya and Weitz, Iris Sonia and Korin, Netanel},
title = {Biomimetic Glycosaminoglycan‐Analog Hydrogel for Improved Embolization of Aneurysms: Environment‐Selective Swelling},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {17},
doi = {10.1002/adhm.202404506}
}
EUVIMED